Table 1 Study populations included in this study
From: Assessment of multiplex Onchocerca volvulus peptide ELISA in non-endemic tropical regions
Group | n | Origin | Helminth infection status | Ov16 IgG4-positive (%) |
|---|---|---|---|---|
Nodule-positive | 84 | Ghana, Ashanti | O. volvulus-infected | 55 (65.5) |
B. malayi | 20 | Indonesia, Central Sulawesi | B. malayi-infected | 0 (0) |
W. bancrofti | 10 | Sri Lanka and Tahiti | W. bancrofti-infected | 0 (0) |
Healthy controls | 84 | Belgium | No helminth infection | nd |
South America | 96 | Brazil/South-America | No helminth infection (90 T. cruzi-seropositive) | nd |
STH/S. mansoni | 24 | Ethiopia, Jimma | STH- and/or S. mansoni-infected | 0 (0) |
Endemic controls | 50 | Ghana, Ashanti | No clinical signs of onchocerciasis | 25 (50.0) |
Kenya, Kisumu | 100 | Kenya, Kisumu | 45 S. mansoni-infected, 3 STH-infected | 0 (0) |
Kenya, Siaya | 108 | Kenya, Siaya | 43 STH-infected, 2 S. mansoni-infected | 1 (0.9) |